Laure Huot

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Patient Reported Outcomes

Top Venues

International journal of technology assessment in health care

This page only lists publications with an associated author ORCID identifier.

Publications

Laure Huot, Pascale Guerre, Guillaume Descotes, Anne-Gaëlle Caffin, Chloé Herledan, Florence Ranchon, Catherine Rioufol
Cost-effectiveness of the ONCORAL multidisciplinary programme for the management of outpatients taking oral anticancer agents at risk of drug-related event: protocol for a pragmatic randomised controlled study. BMJ open 14 (2) (2024)
Ségolène Turquier, Laure Huot, Medhi Lamkhioued, Fabien Subtil, Julie Traclet, Kais Ahmad, François Lestelle, Louis Chauvelot, Vincent Cottin, Jean-François Mornex
Bioreactance assessment of cardiac output lacks reliability for the follow-up of patients with pulmonary hypertension. PloS one 19 (5) (2024)
Laure Huot, Pascale Guerre, Guillaume Descotes, Anne-Gaëlle Caffin, Chloé Herledan, Florence Ranchon, Catherine Rioufol
Cost-effectiveness of the ONCORAL multidisciplinary programme for the management of outpatients taking oral anticancer agents at risk of drug-related event: protocol for a pragmatic randomised controlled study. BMJ open 14 (2) (2024)
Laure Huot, Pascale Guerre, Guillaume Descotes, Anne-Gaëlle Caffin, Chloé Herledan, Florence Ranchon, Catherine Rioufol
Cost-effectiveness of the ONCORAL multidisciplinary programme for the management of outpatients taking oral anticancer agents at risk of drug-related event: protocol for a pragmatic randomised controlled study. BMJ open 14 (2) (2024)
Ségolène Turquier, Laure Huot, Medhi Lamkhioued, Fabien Subtil, Julie Traclet, Kais Ahmad, François Lestelle, Louis Chauvelot, Vincent Cottin, Jean-François Mornex
Bioreactance assessment of cardiac output lacks reliability for the follow-up of patients with pulmonary hypertension. PloS one 19 (5) (2024)
Laure Huot, Pascale Guerre, Guillaume Descotes, Anne-Gaëlle Caffin, Chloé Herledan, Florence Ranchon, Catherine Rioufol
Cost-effectiveness of the ONCORAL multidisciplinary programme for the management of outpatients taking oral anticancer agents at risk of drug-related event: protocol for a pragmatic randomised controlled study. BMJ open 14 (2) (2024)
Tess Martin, Alessandra Guercio, Hélène Besseau, Laure Huot, Pascale Guerre, Jamal Atfeh, Laurent Piazza, Judith Pineau, Brigitte Sabatier, Isabelle Borget, Nicolas Martelli
Hospital-based health technology assessment of innovative medical devices: insights from a nationwide survey in France. International journal of technology assessment in health care 39 (1) (2023)
Bastien Collomb, Amélie Dubromel, Anne Gaëlle Caffin, Chloé Herledan, Virginie Larbre, Amandine Baudouin, Ariane Cerutti, Laurence Couturier, Magali Maire, Lionel Karlin, Delphine Maucort-Boulch, Laure Huot, Stéphane Dalle, Emmanuel Bachy, Hervé Ghesquieres, Gilles Salles, Sébastien Couraud, Benoit You, Gilles Freyer, Véronique Trillet-Lenoir, Florence Ranchon, Catherine Rioufol
Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program. Cancers 14 (3) (2022)